XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.24.3

Portfolio Optimization Plan | 9 Months Ended
--- | ---
Sep. 30, 2024
Portfolio Optimization Plan [Abstract] |
Portfolio Optimization Plan |
2. | Portfolio Optimization Plan
During the fourth quarter of 2023, the Board of Directors of the Company approved a plan to undertake an effort to optimize certain production facilities and improve efficiencies within the Company (Portfolio Optimization Plan). As part of the Portfolio Optimization Plan, in the Flavors & Extracts segment, the Company evaluated the closure of its manufacturing facility in Felinfach, Wales, United Kingdom, the closure of its sales office in Granada, Spain, and the centralization and elimination of certain selling and administrative positions. In addition, in the Color segment, the Company evaluated the closure of a manufacturing facility in Delta, British Columbia, Canada, the closure of a sales office in Argentina, and centralizing and eliminating certain production positions and selling and administrative positions. The Company reports all costs associated with the Portfolio Optimization Plan in the Corporate & Other segment. The Company’s Felinfach site will continue to operate until all production activities have successfully transferred to other locations, and then will be closed. The Company has substantially completed all other actions contemplated under the Portfolio Optimization Plan in accordance with local laws. The Company recorded non-cash impairment charges in Selling and Administrative Expenses, primarily related to certain property, plant, and equipment during the nine months ended September 30, 2024, when the estimated fair value of these assets was lower than the carrying value. The property, plant, and equipment related to a product line that was shut down and determined to not be usable at other plant locations. The Company recorded $2.7 million and $3.7 million of accrued liabilities in Other Accrued Expenses on the Company’s Consolidated Balance Sheet related to the Portfolio Optimization Plan as of September 30, 2024 and December 31, 2023, respectively. The Company expects the Portfolio Optimization Plan will cost approximately $40 million, of which $33.6 million has been incurred through September 30, 2024, primarily related to non-cash impairment charges and proposed employee separation costs, and upon completion would reduce annual operating costs by approximately $8 million to $10 million, with the full benefit expected to be achieved after 2025. The Company anticipates it would reduce headcount by approximately 100 positions, primarily in the Flavors & Extracts and Color segments, related to certain production and selling and administrative positions. The following table summarizes the Portfolio Optimization Plan expenses by segment for the three months ended September 30, 2024:
(In thousands) |  | Flavors & Extracts |  |  | Color |  |  | Corporate & Other |  |  | Consolidated |
Employee separation – Selling and administrative expenses |  | $ | 490 |  |  | $ | 68 |  |  | $ | - |  |  | $ | 558 |
Other production costs – Cost of products sold |  |  | 209 |  |  |  | - |  |  |  | - |  |  |  | 209 |
Other costs – Selling and administrative expenses(1) |  |  | 447 |  |  |  | 9 |  |  |  | (12 | ) |  |  | 444 |
Total |  | $ | 1,146 |  |  | $ | 77 |  |  | $ | (12 | ) |  | $ | 1,211 |
| (1) | Other costs include professional services, accelerated depreciation, and other related costs.
The following table summarizes the Portfolio Optimization Plan expenses by segment for the nine months ended September 30, 2024:
(In thousands) |  | Flavors & Extracts |  |  | Color |  |  | Corporate & Other |  |  | Consolidated |
Non-cash impairment charges – Selling and administrative expenses |  | $ | - |  |  | $ | 1,129 |  |  | $ | - |  |  | $ | 1,129 |
Non-cash charges – Cost of products sold |  |  | 408 |  |  |  | (194 | ) |  |  | - |  |  |  | 214 |
Employee separation – Selling and administrative expenses |  |  | 1,341 |  |  |  | 594 |  |  |  | 28 |  |  |  | 1,963 |
Other production costs – Cost of products sold |  |  | 309 |  |  |  | - |  |  |  | - |  |  |  | 309 |
Other costs – Selling and administrative expenses(1) |  |  | 1,506 |  |  |  | 693 |  |  |  | (39 | ) |  |  | 2,160 |
Total |  | $ | 3,564 |  |  | $ | 2,222 |  |  | $ | (11 | ) |  | $ | 5,775 |
| (1) | Other costs include professional services, decommissioning costs, accelerated depreciation, accelerated lease costs, and other related costs.

X
- References No definition available. + Details
Name: | sxt_PortfolioOptimizationPlanAbstract
Namespace Prefix: | sxt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for portfolio optimization plan. + References No definition available. + Details
Name: | sxt_PortfolioOptimizationPlanTextBlock
Namespace Prefix: | sxt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration